Related Experiment Video
Updated: Aug 5, 2026

07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Metastases to the breast
I Alvarado Cabrero1, M Carrera Alvarez, D Pérez Montiel
1Department of Pathology, Hospital de Oncología del CMN, Siglo XXI, Mexico, Mexico, DF. isa98@prodigy.net.mx
Summary
Metastatic neoplasms to the breast present unique clinico-pathological features. Recognizing these secondary breast tumors can help avoid unnecessary radical surgery.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Breast neoplasms can rarely be metastatic from other primary sites.
- Accurate diagnosis is crucial for appropriate patient management.
Purpose of the Study:
- To describe the clinico-pathological characteristics of metastatic neoplasms to the breast.
- To highlight features that may aid in distinguishing these from primary breast cancers.
Main Methods:
- Retrospective review of a 10-year archive of surgical pathology cases (1990-2000).
- Analysis of 10,650 breast neoplastic cases to identify metastatic lesions.
Main Results:
- 24 cases of metastatic neoplasms to the breast were identified (22 women, 2 men).
- Common primary sites included cutaneous melanoma and ovarian carcinoma.
- Most patients presented with solitary nodules, but multiple lesions occurred.
- A significant proportion (16/24) experienced a rapidly fatal disease course.
Conclusions:
- Metastatic lesions to the breast require careful clinico-pathological evaluation.
- Early recognition can potentially prevent aggressive surgical interventions not indicated for secondary tumors.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

